Antal Zemplenyi
Antal Zemplenyi
University of Pecs and University of Colorado
Verified email at
Cited by
Cited by
Cost‐effectiveness analysis of intensity‐modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer
AT Zemplényi, Z Kaló, G Kovács, R Farkas, T Beöthe, D Bányai, ...
European Journal of Cancer Care 27 (1), e12430, 2018
The effect of performance-volume limit on the DRG based acute care hospital financing in Hungary
D Endrei, A Zemplényi, B Molics, I Ágoston, I Boncz
Health Policy 115 (2-3), 152-156, 2014
Direct healthcare cost of schizophrenia–European overview
G Kovács, T Almási, A Millier, M Toumi, M Horváth, K Kóczián, Á Götze, ...
European Psychiatry 48 (1), 79-92, 2018
Surrogate endpoints in health technology assessment: an international review of methodological guidelines
B Grigore, O Ciani, F Dams, C Federici, S de Groot, M Möllenkamp, ...
Pharmacoeconomics 38 (10), 1055-1070, 2020
The patient at the centre: evidence from 17 European integrated care programmes for persons with complex needs
T Czypionka, M Kraus, M Reiss, E Baltaxe, J Roca, S Ruths, J Stokes, ...
BMC health services research 20, 1-14, 2020
Defining good health and care from the perspective of persons with multimorbidity: results from a qualitative study of focus groups in eight European countries
FRM Leijten, M Hoedemakers, V Struckmann, M Kraus, S Cheraghi-Sohi, ...
BMJ open 8 (8), e021072, 2018
Cost-effectiveness analysis of invasive EEG monitoring in drug-resistant epilepsy
S Kovács, M Tóth, J Janszky, T Dóczi, D Fabó, I Boncz, L Botz, ...
Epilepsy & Behavior 114, 107488, 2021
Barriers to use artificial intelligence methodologies in health technology assessment in central and east European countries
K Tachkov, A Zemplenyi, M Kamusheva, M Dimitrova, P Siirtola, J Pontén, ...
Frontiers in Public Health 10, 921226, 2022
Implementation of palliative care consult Service in Hungary–integration barriers and facilitators
AT Zemplényi, Á Csikós, M Csanádi, MR Mölken, C Hernandez, JG Pitter, ...
BMC palliative care 19, 1-12, 2020
Planning, implementation and operation of a personalized patient management system for subjects with first suspect of cancer (OnkoNetwork): system description based on a …
JG Pitter, M Csanádi, A Szigeti, G Lukács, Á Kovács, M Moizs, I Repa, ...
BMC health services research 19, 1-13, 2019
ápilis 1-i egészségügyi reform intézkedések hatása az összes kórházi ágyszámra
G Vas, G Imhof, I Ágoston, B Vas, J Betlehem, G Kresák, D Endrei, ...
Egészségügyi gazdasági szemle 47 (4), 5-11, 2009
Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive therapy for major depressive disorder (MDD) after two antidepressant treatment failures: meta …
RG Vida, E Sághy, R Bella, S Kovács, D Erdősi, J Józwiak-Hagymásy, ...
BMC psychiatry 23 (1), 545, 2023
Effects of lower screening activity during the COVID-19 pandemic on breast cancer patient pathways: Evidence from the age cut-off of organized screening
P Elek, P Fadgyas-Freyler, B Váradi, B Mayer, A Zemplényi, M Csanádi
Health Policy 126 (8), 763-769, 2022
Quo vadis HTA for medical devices in Central and Eastern Europe? Recommendations to address methodological challenges
R Daubner-Bendes, S Kovács, M Niewada, M Huic, M Drummond, ...
Frontiers in public health 8, 612410, 2021
Behind the subcutaneous trastuzumab hype: evaluation of benefits and their transferability to Central Eastern European countries
A Inotai, T Ágh, AW Karpenko, A Zemplényi, Z Kaló
Expert Review of Pharmacoeconomics & Outcomes Research 19 (2), 105-113, 2019
Regulatory and HTA early dialogues in medical devices
CR Blankart, F Dams, H Penton, Z Kaló, A Zemplényi, K Shatrov, ...
Health Policy 125 (10), 1322-1329, 2021
Recurrent acute pancreatitis prevention by the elimination of alcohol and cigarette smoking (REAPPEAR): protocol of a randomised controlled trial and a cohort study
K Ocskay, MF Juhász, N Farkas, N Zádori, L Szakó, Z Szakács, A Szentesi, ...
BMJ open 12 (1), e050821, 2022
Repetitive transcranial magnetic stimulation may be a cost-effective alternative to antidepressant therapy after two treatment failures in patients with major depressive disorder
A Zemplényi, J Józwiak-Hagymásy, S Kovács, D Erdősi, I Boncz, T Tényi, ...
BMC psychiatry 22 (1), 437, 2022
Heterogeneous impact of the COVID-19 pandemic on lung, colorectal and breast cancer incidence in Hungary: results from time series and panel data models
P Elek, M Csanádi, P Fadgyas-Freyler, N Gervai, R Oross-Bécsi, ...
BMJ open 12 (8), e061941, 2022
Using real-world evidence in healthcare from Western to Central and Eastern Europe: a review of existing barriers
M Kamusheva, B Nemeth, A Zemplenyi, Z Kalo, J Elvidge, M Dimitrova, ...
Journal of Comparative Effectiveness Research 11 (12), 905-913, 2022
The system can't perform the operation now. Try again later.
Articles 1–20